🇺🇸 FDA
Patent

US 11594135

Methods of CD40 activation and immune checkpoint blockade

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 11594135 (Methods of CD40 activation and immune checkpoint blockade) held by The Board of Regents of the University of Texas System expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K2039/55